Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kerr

Showing results (171-180 of 221) with videos related to

Pageof 23
Sort By:
Blood|May 1, 1992
Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivoD J Dunlop, E G Wright, S Lorimore, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTGJ Cassidy, M A Graham, W Ten Bokkel Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervixR P Symonds, T Habeshaw, J Paul, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I and pharmacokinetic study of intraperitoneal thioTEPA in patients with ovarian cancerC Lewis, N Lawson, E M Rankin, et al.
Cancer Gene Therapy|June 1, 2000
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954A H Djeha, A Hulme, M T Dexter, et al.
Gene Therapy|November 13, 2001
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferaseG A Chung-Faye, M J Chen, N K Green, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1992
Glass yttrium-90 microspheres for patients with colorectal liver metastasesJ H Anderson, J A Goldberg, R G Bessent, et al.
Nuclear Medicine Communications|August 1, 1989
Clinical evaluation of angiotensin II enhanced perfusion scintigraphy in metastatic liver diseaseJ A Goldberg, J Fenner, R G Bessent, et al.
Nuclear Medicine Communications|December 1, 1987
Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin IIJ A Goldberg, M S Bradnam, D J Kerr, et al.
Gene Therapy|May 18, 1999
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954I A McNeish, N K Green, M G Gilligan, et al.
Pageof 23

Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
Blood|May 1, 1992
Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivoD J Dunlop, E G Wright, S Lorimore, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase I clinical study of LL-D49194 alpha 1 with retrospective pharmacokinetic investigations in mice and humans. The EORTC ECTGJ Cassidy, M A Graham, W Ten Bokkel Huinink, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervixR P Symonds, T Habeshaw, J Paul, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase I and pharmacokinetic study of intraperitoneal thioTEPA in patients with ovarian cancerC Lewis, N Lawson, E M Rankin, et al.
Cancer Gene Therapy|June 1, 2000
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954A H Djeha, A Hulme, M T Dexter, et al.
Gene Therapy|November 13, 2001
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferaseG A Chung-Faye, M J Chen, N K Green, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 1, 1992
Glass yttrium-90 microspheres for patients with colorectal liver metastasesJ H Anderson, J A Goldberg, R G Bessent, et al.
Nuclear Medicine Communications|August 1, 1989
Clinical evaluation of angiotensin II enhanced perfusion scintigraphy in metastatic liver diseaseJ A Goldberg, J Fenner, R G Bessent, et al.
Nuclear Medicine Communications|December 1, 1987
Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin IIJ A Goldberg, M S Bradnam, D J Kerr, et al.
Gene Therapy|May 18, 1999
Virus directed enzyme prodrug therapy for ovarian and pancreatic cancer using retrovirally delivered E. coli nitroreductase and CB1954I A McNeish, N K Green, M G Gilligan, et al.
Pageof 23